 |
|
Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study
Gi Hyeon Seo, Hyung Jin Choi
J Bone Metab. 2015;22(2):77-81. Published online 2015 May 31 DOI: https://doi.org/10.11005/jbm.2015.22.2.77
|
|
Citations to this article as recorded by
 Bisphosphonates and risk of lung cancer
Minghao Li, Muyan Zhong, Chengnong Guan
Medicine.2021; 100(1): e22839. CrossRef Bisphosphonates and risk of oesophageal cancer: A meta‐analysis
Minghao Li, Muyan Zhong
GastroHep.2020; 2(3): 123. CrossRef Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
Yeesuk Kim, Yuxi Tian, Jianxiao Yang, Vojtech Huser, Peng Jin, Christophe G. Lambert, Hojun Park, Seng Chan You, Rae Woong Park, Peter R. Rijnbeek, Mui Van Zandt, Christian Reich, Rohit Vashisht, Yonghui Wu, Jon Duke, George Hripcsak, David Madigan, Nigam
Scientific Reports.2020;[Epub] CrossRef Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry
Hyun Koo Yoon, Young-Kyun Lee, Yong-Chan Ha
Journal of Bone Metabolism.2017; 24(1): 59. CrossRef Incidence of permanent hypocalcaemia after total thyroidectomy with or without central neck dissection for thyroid carcinoma: a nationwide claim study
Gi Hyeon Seo, Young Jun Chai, Hyung Jin Choi, Kyu Eun Lee
Clinical Endocrinology.2016; 85(3): 483. CrossRef Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea
Sun-Young Jung, Hyun Soon Sohn, Eun-Ja Park, Hae Sun Suh, Ji-Won Park, Jin-Won Kwon, Chi-Ling Chen
PLOS ONE.2016; 11(3): e0150531. CrossRef
|